Abstract
Background: Squamous cell carcinoma has a stronger association with tobacco smoking than other non-small cell lung cancers (NSCLC). A study was undertaken to determine whether chronic obstructive pulmonary disease (COPD) is a risk factor for the squamous cell carcinoma histological subtype in smokers with surgically resectable NSCLC.
Methods: Using a case-control design, subjects with a surgically confirmed diagnosis of squamous cell carcinoma were enrolled from smokers undergoing lung resection for NSCLC in the District Hospital of Ferrara, Italy. Control subjects were smokers who underwent lung resection for NSCLC in the same hospital and had a surgically confirmed diagnosis of NSCLC of any histological type other than squamous cell.
Results: Eighty six cases and 54 controls (mainly adenocarcinoma, n = 50) were enrolled. The presence of COPD was found to increase the risk for the squamous cell histological subtype by more than four times. Conversely, the presence of chronic bronchitis was found to decrease the risk for this histological subtype by more than four times. Among patients with chronic bronchitis (n = 77), those with COPD had a 3.5 times higher risk of having the squamous cell histological subtype.
Conclusions: These data suggest that, among smokers with surgically resectable NSCLC, COPD is a risk factor for the squamous cell histological subtype and chronic bronchitis, particularly when not associated with COPD, is a risk factor for the adenocarcinoma histological subtype.
Full Text
The Full Text of this article is available as a PDF (50.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Auerbach O., Hammond E. C., Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med. 1979 Feb 22;300(8):381–385. doi: 10.1056/NEJM197902223000801. [DOI] [PubMed] [Google Scholar]
- Congleton J., Muers M. F. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med. 1995 Apr;89(4):291–296. doi: 10.1016/0954-6111(95)90090-x. [DOI] [PubMed] [Google Scholar]
- Janssen-Heijnen M. L., Coebergh J. W. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer. 2001 Feb-Mar;31(2-3):123–137. doi: 10.1016/s0169-5002(00)00197-5. [DOI] [PubMed] [Google Scholar]
- Mountain C. F. Revisions in the International System for Staging Lung Cancer. Chest. 1997 Jun;111(6):1710–1717. doi: 10.1378/chest.111.6.1710. [DOI] [PubMed] [Google Scholar]
- Pauwels R. A., Buist A. S., Calverley P. M., Jenkins C. R., Hurd S. S., GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 Apr;163(5):1256–1276. doi: 10.1164/ajrccm.163.5.2101039. [DOI] [PubMed] [Google Scholar]
- Segal R. A., Martonen T. B., Kim C. S., Shearer M. Computer simulations of particle deposition in the lungs of chronic obstructive pulmonary disease patients. Inhal Toxicol. 2002 Jul;14(7):705–720. doi: 10.1080/08958370290084593. [DOI] [PubMed] [Google Scholar]
- Wang S. Y., Hu Y. L., Wu Y. L., Li X., Chi G. B., Chen Y., Dai W. S. A comparative study of the risk factors for lung cancer in Guangdong, China. Lung Cancer. 1996 Mar;14 (Suppl 1):S99–105. doi: 10.1016/s0169-5002(96)90215-9. [DOI] [PubMed] [Google Scholar]